Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mural Oncology plc | Director | Stock Option (right to buy) | 15.3K | $51.4K | $3.35 | Jul 30, 2024 | Direct |
Shattuck Labs, Inc. | Director | Stock Option (Right to Buy) | 27.7K | Jun 21, 2024 | Direct | ||
Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.5K | Jun 10, 2024 | Direct |